From the Sector

Reset
24.07.2024

AkzoNobel publishes results for Q2 2024

Highlights Q2 2024 (compared with Q2 2023)

  • Organic sales up 2%, with volumes up 1%; Revenue up 2%
  • Operating income €270 million (2023: €279 million)
  • Adjusted EBITDA €400 million (2023: €397 million); Adjusted EBITDA margin 14.4% (2023: 14.5%)
  • Net cash from operating activities positive €151 million (2023: positive €305 million)

Highlights half-year 2024 (compared with half-year 2023)

  • Organic sales up 2%, driven by higher volumes and positive price/mix; revenue flat
  • Operating income €531 million (2023: €461 million)
  • Adjusted EBITDA €763 million (2023: €702 million); Adjusted EBITDA margin 14.1% (2023: 13.0%)
  • Net cash from operating activities negative €19 million (2023: positive €255 million)

Outlook
Based on current market conditions and constant currencies, AkzoNobel expects to deliver 2024 adjusted EBITDA towards the lower end of its full-year guidance range of €1.5 to €1.65 billion.

Highlights Q2 2024 (compared with Q2 2023)

  • Organic sales up 2%, with volumes up 1%; Revenue up 2%
  • Operating income €270 million (2023: €279 million)
  • Adjusted EBITDA €400 million (2023: €397 million); Adjusted EBITDA margin 14.4% (2023: 14.5%)
  • Net cash from operating activities positive €151 million (2023: positive €305 million)

Highlights half-year 2024 (compared with half-year 2023)

  • Organic sales up 2%, driven by higher volumes and positive price/mix; revenue flat
  • Operating income €531 million (2023: €461 million)
  • Adjusted EBITDA €763 million (2023: €702 million); Adjusted EBITDA margin 14.1% (2023: 13.0%)
  • Net cash from operating activities negative €19 million (2023: positive €255 million)

Outlook
Based on current market conditions and constant currencies, AkzoNobel expects to deliver 2024 adjusted EBITDA towards the lower end of its full-year guidance range of €1.5 to €1.65 billion.

More information:
AkzoNobel financial year 2024
Source:

AkzoNobel